| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/30/2009 | US20090110742 Long-acting colloidal insulin formulation and its preparation |
| 04/30/2009 | US20090110738 Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | US20090110730 Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110713 Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices |
| 04/30/2009 | US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 04/30/2009 | DE102007051059A1 Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen Biomaterial for the controlled release of active ingredients |
| 04/30/2009 | CA2740960A1 Immuno-modulatory composition |
| 04/30/2009 | CA2703496A1 Lipid-modified double-stranded rna having potent rna interference effect |
| 04/30/2009 | CA2703313A1 Oral dosage forms comprising licarbazepine acetate |
| 04/30/2009 | CA2703140A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | CA2702800A1 Long acting injectable formulations |
| 04/30/2009 | CA2702506A1 Anti-malarial pharmaceutical composition |
| 04/30/2009 | CA2700711A1 Use of metal astringents for the treatment and prevention of hairy heel warts |
| 04/30/2009 | CA2699894A1 Cholesterol derivatives of inhibitors of viral fusion |
| 04/29/2009 | EP2053063A1 Recognition molecules for treatment and detection of tumours |
| 04/29/2009 | EP2052742A1 Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination |
| 04/29/2009 | EP2052740A1 Crosslinked gelatin gel multilayered structure, carrier for bioactive factor, preparation for release of bioactive factor, and their production methods |
| 04/29/2009 | EP2052736A1 Parathyroid hormone formulations und uses thereof |
| 04/29/2009 | EP2052723A1 Stable lyophilized preparation |
| 04/29/2009 | EP2052718A1 Patch preparation |
| 04/29/2009 | EP2052716A1 Controlled release formulations |
| 04/29/2009 | EP2052714A1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP2052253A2 Immunogenic compounds and protein mimics |
| 04/29/2009 | EP2052081A1 Fusion proteins and methods for modulation of immune response |
| 04/29/2009 | EP2052011A1 Targeted polylysine dendrimer therapeutic agent |
| 04/29/2009 | EP2051738A2 Drug delivery system based on regioselectively amidated hyaluronic acid |
| 04/29/2009 | EP2051737A2 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/29/2009 | EP2051735A2 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 04/29/2009 | EP2051697A2 Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof |
| 04/29/2009 | EP2051696A2 Stable liquid levetiracetam compositions and methods |
| 04/29/2009 | EP2051694A2 Pharmaceutical compositions comprising aripiprazole |
| 04/29/2009 | EP1620065A4 Oral care tablet |
| 04/29/2009 | EP1552822B1 Patch |
| 04/29/2009 | EP1509207B1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 04/29/2009 | EP1485072B1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion. |
| 04/29/2009 | EP1407787B1 Method of promoting nucleic acid transfer |
| 04/29/2009 | EP1343475B1 Self forming, thermodynamically stable liposomes |
| 04/29/2009 | EP1313482B1 Pharmaceutical composition and method for treating hypogonadism |
| 04/29/2009 | EP1304992B1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP1296652B1 Topical pharmaceutical formulations and methods of treatment |
| 04/29/2009 | EP1119345B1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 04/29/2009 | EP1047433A4 Cellulose derivatives and colorectal cancer risk reduction |
| 04/29/2009 | CN101421395A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 04/29/2009 | CN101421293A Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 04/29/2009 | CN101420991A Polymer compositions and methods for their use |
| 04/29/2009 | CN101420988A Sanitary napkins with hydrophobic lotions |
| 04/29/2009 | CN101420984A Segmented degradable polymers and conjugates made therefrom |
| 04/29/2009 | CN101420983A Methods and compositions comprising supramolecular constructs |
| 04/29/2009 | CN101420982A Dry direct compression fast disintegrating tablet |
| 04/29/2009 | CN101420972A Methods for reducing protein aggregation |
| 04/29/2009 | CN101420967A Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability |
| 04/29/2009 | CN101420962A Modified macromolecule |
| 04/29/2009 | CN101420946A Tamsulosin-containing percutaneous absorption type preparation |
| 04/29/2009 | CN101420943A Chewing composition containing coenzyme Q10 |
| 04/29/2009 | CN101420937A Method for producing extended release tablet |
| 04/29/2009 | CN101420936A Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 04/29/2009 | CN101420934A Methods for stabilizing oxidatively unstable compositions |
| 04/29/2009 | CN101420931A Solid preparation for oral application |
| 04/29/2009 | CN101418192A Hydrophilicity hot melt type polyurethane contact adhesive and preparation method and use |
| 04/29/2009 | CN101417845A Method for changing inherent structure of water and enhancing basic function of water |
| 04/29/2009 | CN101417134A Hyaluronic acid decorated novel tertiary structure non-virogene transmission system and use thereof |
| 04/29/2009 | CN101417133A Slow-release medicine intercalation magnetic hydrotalcite with fluorescence radiation performance and preparation method thereof |
| 04/29/2009 | CN101417122A Recombination chicken alpha-interferon injection and preparation method thereof |
| 04/29/2009 | CN101417105A Zedoary turmeric oil glucose injection and preparation method thereof |
| 04/29/2009 | CN101417072A Effervescence tablet for treating gynecologic disease |
| 04/29/2009 | CN101417044A Preparation method Kwangtung purple beautyberry extract and new use thereof |
| 04/29/2009 | CN101417008A Biberberine for injection as veterinary herb medicine composite preparation and preparation technique and use thereof |
| 04/29/2009 | CN101417007A Traditional Chinese medicine formulation for treating non-insulin dependent diabetes mellitus and preparation method and use thereof |
| 04/29/2009 | CN101417005A Gentian bitterness concealing technique in oral liquid |
| 04/29/2009 | CN101416992A Beggarticks dispersion tablets and preparation method thereof |
| 04/29/2009 | CN101416978A Preparation method of tilmicosin long-acting injection |
| 04/29/2009 | CN101416977A Preparation method of azalide type tulathromvcin injection |
| 04/29/2009 | CN101416974A Preparation method of doxycycline long-acting injection |
| 04/29/2009 | CN101416968A Preparation method of ceftiofur long-acting injector |
| 04/29/2009 | CN101416965A Oral nifedipine slow-release preparation and preparation method thereof |
| 04/29/2009 | CN101416956A Ambroxol hydrochloride injection |
| 04/29/2009 | CN101416955A Improved cataplasm ground-mass and use thereof |
| 04/29/2009 | CN101416952A Effervescent disintegrant containing sodium bicarbonate micro-capsules and preparation method thereof |
| 04/29/2009 | CN101416950A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416949A Pharmaceutical compositions of estrogenic agents |
| 04/29/2009 | CN101416946A Biodegradable implantation controlled-release microsphere using vibration membrane technique |
| 04/29/2009 | CN101416944A Sodium ferulic acid nano micelle preparation and preparation method thereof |
| 04/29/2009 | CN101416941A Medical composition loaded with nimustine and synergist thereof |
| 04/29/2009 | CN101416938A Slow-released injection containing nolatrexed dihydrochloride and synergist thereof |
| 04/29/2009 | CN101416934A Calcium gluconate gel |
| 04/29/2009 | CN100482676C N-oxy-group-contained lipids |
| 04/29/2009 | CN100482637C Compounds and compositions for delivering active agents |
| 04/29/2009 | CN100482282C High water-soluble prodrug, and its preparing method and pharmaceutical use |
| 04/29/2009 | CN100482281C Method of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 04/29/2009 | CN100482280C Highly compressible ethylcellulose for tableting |
| 04/29/2009 | CN100482279C Chinese herb medicine composition in the form of jelly |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/29/2009 | CN100482277C Calicheamicin derivative-carrier conjugates |
| 04/29/2009 | CN100482272C Dry heat processing stabilizer for prothrombin complex or factor v a IX preparation |
| 04/29/2009 | CN100482262C Herbal pharmaceutical compositions for treating immun logical disorders |
| 04/29/2009 | CN100482241C Quickly-acting defervescence plaster used for infants and preparation method thereof |
| 04/29/2009 | CN100482231C Cefepime hydrochloride powder injection and preparing method thereof |
| 04/29/2009 | CN100482226C Composition for covering flavor and preparation of containing the composition |
| 04/29/2009 | CN100482220C Oral preparation of bilobalide with high bioavailability and preparation method thereof |